期刊书目 › HEMATOLOGY(血液学) › ESCI期刊Hematology Transfusion and Cell Therapy 2024/2025影响因子:1.876 (HEMATOL TRANSF CELL) (2531-1379). (HEMATOLOGY)(血液学)E

从容 发表于 2025-3-26 22:34:18

Submitted on: 01 December 2021.
Revised on: 30 January 2022.
Accepted on: 21 February 2022.

___________________Hematology Transfusion and Cell Therapy

NAUT 发表于 2025-3-27 03:51:48

Submitted on: 02 August 2016.
Revised on: 22 October 2016.
Accepted on: 07 November 2016.

___________________Hematology Transfusion and Cell Therapy

SKIFF 发表于 2025-3-27 06:59:38

http://reply.papertrans.cn/2/113/11210/11210-33.png

Charade 发表于 2025-3-27 10:00:39

Submitted on: 20 October 2002.
Revised on: 13 January 2003.
Accepted on: 06 February 2003.

___________________Hematology Transfusion and Cell Therapy

不合 发表于 2025-3-27 13:45:57

http://reply.papertrans.cn/2/113/11210/11210-35.png

贞洁 发表于 2025-3-27 17:56:28

http://reply.papertrans.cn/2/113/11210/11210-36.png

查看完整版本: ESCI期刊Hematology Transfusion and Cell Therapy 2024/2025影响因子:1.876 (HEMATOL TRANSF CELL) (2531-1379). (HEMATOLOGY)(血液学)E